Evidence check a specific claim separated from advice

Peripheral nerve stimulation is a selected option for refractory chronic pain, not a general first-line treatment

draft Verdict: true
Evidence summary
Evidence quality
specialty-guideline support, but narrow scope
Confidence
low
Last reviewed
2026-05-30

Inside the larger guide

This claim sits inside What non-opioid treatments actually help chronic pain?

This page checks one premise in the broader answer. Open the guide when you want the full decision, the main tradeoffs, and the practical default in one place.

Full guide What non-opioid treatments actually help chronic pain? Evidence: moderate

How to read this page

What this evidence check is doing

Verdict true Confidence: low
Evidence basis 1 proof source 1 source record cited overall
Why it matters 1 guide 1 practical option depend on this claim

This page is for checking one narrower judgment carefully. Read it when you want to know what the evidence supports, where the limits are, and how much of the broader guide depends on this claim.

Focused evidence check

What this claim means

Bottom line

Peripheral nerve stimulation may help selected patients whose chronic pain has not responded well to standard care. The ASIPP guideline supports its use as a specialized option, which makes it part of the non-opioid landscape.

What seems true

What is true is that this is a reasonable consideration in refractory cases. What is not proven is that it should be used broadly or before simpler non-opioid treatments.

What is uncertain or overstated

The practical meaning is that PNS belongs later in the pathway, after the more established medication, rehabilitation, and behavioral options have been considered.

Practical meaning

This judgment mainly rests on sources such as Comprehensive Evidence-Based Guidelines for Implantable Peripheral Nerve Stimulation (PNS) in the Management of Chronic Pain: From the American Society Of Interventional Pain Physicians (ASIPP) (guideline). Together they give the evidence base for the claim, but the confidence still depends on how direct, consistent, and decision-relevant those sources really are.

Key sources for this judgment include Comprehensive Evidence-Based Guidelines for Implantable Peripheral Nerve Stimulation (PNS) in the Management of Chronic Pain: From the American Society Of Interventional Pain Physicians (ASIPP).

Source support

Main sources behind this claim

Supporting source

Comprehensive Evidence-Based Guidelines for Implantable Peripheral Nerve Stimulation (PNS) in the Management of Chronic Pain: From the American Society Of Interventional Pain Physicians (ASIPP)

Quality: medium ยท guideline

The guideline is published by the American Society of Interventional Pain Physicians and indexed in PubMed. That gives it clinical relevance for interventional pain care, while also making clear that it is a specialty guideline rather than a broad primary-care consensus.

Used to support the limited role of peripheral nerve stimulation as a selected option for refractory chronic pain. It does not prove that PNS should be used broadly or before simpler non-opioid therapies.